Epilepsy News

Seizure action plans: Management and educational tools in epilepsy care - Historically, seizure action plans have focused on certain high-risk groups—such as people with drug-resistant epilepsy and people with a history of status epilepticus or seizure clusters. Neurology ...

Wearable Tech Advances in Epilepsy Seizure Detection - A narrative review published in Acta Epileptologica on March 2, 2026, synthesizes the current state of wearable digital health technologies in epilepsy management.

Seizure action plans: More than management tools for epilepsy - Newswise — Historically, seizure action plans have focused on certain high-risk groups — such as people with drug-resistant epilepsy and people with a history of status epilepticus or seizure clusters ...

Epilepsy comes out of nowhere: Heartland neurologist discusses misconceptions about seizures - Dr. Mark Farrenburg said he wants people to know the difference between having a seizure and an epilepsy diagnosis this Seizure Awareness month.

Does Levetiracetam Improve Seizure Outcomes in Pediatric Epilepsy? - Although levetiracetam was associated with improved seizure outcomes compared with placebo in pediatric epilepsy, it did not demonstrate superior efficacy when compared with established active ...

First seizure clinic provides visit, pediatric epilepsy diagnosis in less than a week - Please provide your email address to receive an email when new articles are posted on . The model expedites access to specialists after a first seizure. The mean time between the referral and the ...

What Is Neurofeedback Therapy? - Neurofeedback is a noninvasive form of therapy that trains the brain to improve various neurological issues, including chronic pain, ADHD, anxiety, depression and PTSD. Using EEG to monitor real-time ...

Elite athletes enhance their performance with 'neurofeedback'—and you can get a device for $99 - When you think of the training tools that professional athletes have at their disposal, high-tech sports equipment and state-of-the-art athletic facilities come to mind. But training for peak ...

What Is Neurofeedback Therapy And How Does It Work? - Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...

Systematic Review Finds Few Active Controlled Benefits in Athlete Neurofeedback Studies - A systematic review of 56 athletic neurofeedback studies reveals that while positive outcomes are widely reported, only 18 percent demonstrate benefits over active control groups.

What Is Neurofeedback? - Whenever I mention that neurofeedback helped me regain my life after my multiple brain injuries — or that I’m now a neurofeedback provider — the first reaction is to ask me, what is neurofeedback? I’m ...

Novel gene therapy lets drug dampen brain cell activity, reducing seizures - In first clinical result using "chemogenetic" strategy, a team in China treated three patients to control epilepsy.

Functional characterization and pharmacochaperone rescue of a novel SLC6A1 variant associated with developmental epileptic encephalopathies - Mutations in SLC6A1, encoding the γ-aminobutyric acid (GABA) transporter 1 (GAT-1), are associated with a spectrum of neurodevelopmental disorders, including epilepsy syndromes, intellectual disability (ID), and autism. An important question is whether the impact of these mutations can be predicted at scale using artificial intelligence (AI), and how such predictions correlate with experimental...

Sudden Unexpected Death in Epilepsy: Mechanisms, Biomarkers, and Unanswered Questions - PURPOSE OF REVIEW: Sudden unexpected death in epilepsy (SUDEP) remains the leading cause of epilepsy-related mortality. While heterogeneous in its pathophysiology, a significant proportion of cases are likely attributable to cardiorespiratory collapse following a convulsive seizure. We synthesize recent mechanistic, biomarker, and prevention literature, moving from retrospective risk inference ...

Epilepsy genetics in Africa: a systematic review - CONCLUSION: This study highlights substantial clinical and genetic heterogeneity of epilepsy in Africa with population-specific founder variants. Notably, only a limited number of African countries (12/54) have published on molecular diagnostics for epilepsy. The data suggest the potential for significant discoveries yet to be made but also point to ongoing disparities in the availability of ge...

Epileptiform Discharges in Seizure-Free Children with Autism Spectrum Disorder and the Role of Antiseizure Medications - CONCLUSION: EPDs are common in children with ASD, even in the absence of clinical seizures. When ASMs were used consistently, EEG improvements were observed, and ASD severity scores on the CARS-2 were reduced. Key Words: Anti-seizure medications, Autism spectrum disorder, Electroencephalography, Epileptiform discharges.

Adjunctive Brivaracetam in Early Treatment Line Combinations: 12-Month Real-World Experience and Impact on Health Outcomes in Adult Patients with Focal Seizures - CONCLUSIONS: In adults with focal seizures, BRV in earlier ASM regimens was effective and well tolerated. At 12 months, there were improvements in quality of life, clinical condition, work productivity, and treatment satisfaction.

Brain signal irregularity may provide clues to understanding epileptic process - Researchers propose a new method to differentiate signals from the epileptic focus from those recorded in other parts of the brain without the presence of an epileptic seizure. This technique may help detect epilepsy-induced features from these signals much quicker than conventional analysis techniques.

Breakthrough tech enables seizure localization in minutes - New research introduces a novel network analysis technology that uses minimally invasive resting state electrophysiological recordings to localize seizure onset brain regions and predict seizure outcomes in just 10 minutes.

Antidepressant use during pregnancy not linked to epilepsy in children - A new study suggests that antidepressant use by mothers during the first trimester of pregnancy does not increase the chances of epilepsy and seizures in babies.